Pitavastatin

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1318 publications

Associations between inflammatory markers and myocardial injury in patients treated with pitavastatin : A retrospective clinical study.

Associations between inflammatory markers and myocardial injury in patients treated with pitavastatin : A retrospective clinical study.

Journal: Pakistan journal of pharmaceutical sciences

Published: August 22, 2026

Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1(4):100036.

Erratum: Brem EA, Shieh K, Juarez D, et al. A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy. Blood Neoplasia. 2024;1(4):100036.

Journal: Blood neoplasia

Published: August 15, 2026

Shared genetics of IgA nephropathy and cardiometabolic diseases revealed by integrative genomic analysis.

Shared genetics of IgA nephropathy and cardiometabolic diseases revealed by integrative genomic analysis.

Journal: Renal failure

Published: July 31, 2026

Formulation and evaluation of sustained-release pitavastatin-loaded chitosan nanoparticles for enhanced anti-hyperlipidemic activity.

Formulation and evaluation of sustained-release pitavastatin-loaded chitosan nanoparticles for enhanced anti-hyperlipidemic activity.

Journal: Pakistan journal of pharmaceutical sciences

Published: July 23, 2026

Enantiodivergent C3-Selective Reduction of Arylvinyl-Substituted 3,5-Dicarbonyl Esters Enabled by Engineered Ketoreductases.

Enantiodivergent C3-Selective Reduction of Arylvinyl-Substituted 3,5-Dicarbonyl Esters Enabled by Engineered Ketoreductases.

Journal: Organic letters

Published: July 09, 2026

Mechanisms and Predisposing Conditions for Statin-Induced New-Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects.

Mechanisms and Predisposing Conditions for Statin-Induced New-Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects.

Journal: Endocrinology, diabetes & metabolism

Published: July 07, 2026

Drugs for hypercholesterolemia.

Drugs for hypercholesterolemia.

Journal: The Medical letter on drugs and therapeutics

Published: June 01, 2026

Comparison chart: Statins.

Comparison chart: Statins.

Journal: The Medical letter on drugs and therapeutics

Published: June 01, 2026

Dyslipidemia Management in the Middle East: Recommendations for Overcoming Challenges and Enhancing Outcomes With Pitavastatin.

Dyslipidemia Management in the Middle East: Recommendations for Overcoming Challenges and Enhancing Outcomes With Pitavastatin.

Journal: Cureus

Published: May 30, 2026

Combination pitavastatin-ezetimibe therapy for hypercholesterolemia and mixed dyslipidemia: a systematic review and meta-analysis.

Combination pitavastatin-ezetimibe therapy for hypercholesterolemia and mixed dyslipidemia: a systematic review and meta-analysis.

Journal: Future cardiology

Published: May 25, 2026

Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.

Drug repurposing of fluvastatin as a DP2 antagonist: an ensemble learning strategy with in vitro cellular functional validation.

Journal: RSC medicinal chemistry

Published: May 20, 2026

CROI 2026: HIV Comorbidities.

CROI 2026: HIV Comorbidities.

Journal: Topics in antiviral medicine

Published: May 13, 2026

Showing 1-12 of 1,318

Last Updated: 09/26/2026